Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Gastroenterology ; 165(4): 874-890.e10, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37263309

RESUMEN

BACKGROUND & AIMS: Transforming growth factor-b (TGFb) plays pleiotropic roles in pancreatic cancer, including promoting metastasis, attenuating CD8 T-cell activation, and enhancing myofibroblast differentiation and deposition of extracellular matrix. However, single-agent TGFb inhibition has shown limited efficacy against pancreatic cancer in mice or humans. METHODS: We evaluated the TGFß-blocking antibody NIS793 in combination with gemcitabine/nanoparticle (albumin-bound)-paclitaxel or FOLFIRINOX (folinic acid [FOL], 5-fluorouracil [F], irinotecan [IRI] and oxaliplatin [OX]) in orthotopic pancreatic cancer models. Single-cell RNA sequencing and immunofluorescence were used to evaluate changes in tumor cell state and the tumor microenvironment. RESULTS: Blockade of TGFß with chemotherapy reduced tumor burden in poorly immunogenic pancreatic cancer, without affecting the metastatic rate of cancer cells. Efficacy of combination therapy was not dependent on CD8 T cells, because response to TGFß blockade was preserved in CD8-depleted or recombination activating gene 2 (RAG2-/-) mice. TGFß blockade decreased total α-smooth muscle actin-positive fibroblasts but had minimal effect on fibroblast heterogeneity. Bulk RNA sequencing on tumor cells sorted ex vivo revealed that tumor cells treated with TGFß blockade adopted a classical lineage consistent with enhanced chemosensitivity, and immunofluorescence for cleaved caspase 3 confirmed that TGFß blockade increased chemotherapy-induced cell death in vivo. CONCLUSIONS: TGFß regulates pancreatic cancer cell plasticity between classical and basal cell states. TGFß blockade in orthotropic models of pancreatic cancer enhances sensitivity to chemotherapy by promoting a classical malignant cell state. This study provides scientific rationale for evaluation of NIS793 with FOLFIRINOX or gemcitabine/nanoparticle (albumin-bound) paclitaxel chemotherapy backbone in the clinical setting and supports the concept of manipulating cancer cell plasticity to increase the efficacy of combination therapy regimens.


Asunto(s)
Antineoplásicos , Neoplasias Pancreáticas , Humanos , Ratones , Animales , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patología , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Factor de Crecimiento Transformador beta/metabolismo , Antineoplásicos/uso terapéutico , Gemcitabina , Paclitaxel/farmacología , Paclitaxel/uso terapéutico , Albúminas , Factores de Crecimiento Transformadores/uso terapéutico , Microambiente Tumoral , Neoplasias Pancreáticas
2.
Cancer Discov ; 14(11): 2135-2161, 2024 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-38975874

RESUMEN

KRAS inhibitors demonstrate clinical efficacy in pancreatic ductal adenocarcinoma (PDAC); however, resistance is common. Among patients with KRASG12C-mutant PDAC treated with adagrasib or sotorasib, mutations in PIK3CA and KRAS, and amplifications of KRASG12C, MYC, MET, EGFR, and CDK6 emerged at acquired resistance. In PDAC cell lines and organoid models treated with the KRASG12D inhibitor MRTX1133, epithelial-to-mesenchymal transition and PI3K-AKT-mTOR signaling associate with resistance to therapy. MRTX1133 treatment of the KrasLSL-G12D/+; Trp53LSL-R172H/+; p48-Cre (KPC) mouse model yielded deep tumor regressions, but drug resistance ultimately emerged, accompanied by amplifications of Kras, Yap1, Myc, Cdk6, and Abcb1a/b, and co-evolution of drug-resistant transcriptional programs. Moreover, in KPC and PDX models, mesenchymal and basal-like cell states displayed increased response to KRAS inhibition compared to the classical state. Combination treatment with KRASG12D inhibition and chemotherapy significantly improved tumor control in PDAC mouse models. Collectively, these data elucidate co-evolving resistance mechanisms to KRAS inhibition and support multiple combination therapy strategies. Significance: Acquired resistance may limit the impact of KRAS inhibition in patients with PDAC. Using clinical samples and multiple preclinical models, we define heterogeneous genetic and non-genetic mechanisms of resistance to KRAS inhibition that may guide combination therapy approaches to improve the efficacy and durability of these promising therapies for patients. See related commentary by Marasco and Misale, p. 2018.


Asunto(s)
Resistencia a Antineoplásicos , Neoplasias Pancreáticas , Proteínas Proto-Oncogénicas p21(ras) , Humanos , Proteínas Proto-Oncogénicas p21(ras)/genética , Animales , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patología , Neoplasias Pancreáticas/metabolismo , Ratones , Línea Celular Tumoral , Carcinoma Ductal Pancreático/tratamiento farmacológico , Carcinoma Ductal Pancreático/genética , Carcinoma Ductal Pancreático/patología , Mutación , Pirimidinas/farmacología , Pirimidinas/uso terapéutico
3.
Cell Rep ; 37(13): 110181, 2021 12 28.
Artículo en Inglés | MEDLINE | ID: mdl-34965432

RESUMEN

The EGFR/Erk pathway is triggered by extracellular ligand stimulation, leading to stimulus-dependent dynamics of pathway activity. Although mechanical properties of the microenvironment also affect Erk activity, their effects on Erk signaling dynamics are poorly understood. Here, we characterize how the stiffness of the underlying substratum affects Erk signaling dynamics in mammary epithelial cells. We find that soft microenvironments attenuate Erk signaling, both at steady state and in response to epidermal growth factor (EGF) stimulation. Optogenetic manipulation at multiple signaling nodes reveals that intracellular signal transmission is largely unaffected by substratum stiffness. Instead, we find that soft microenvironments decrease EGF receptor (EGFR) expression and alter the amount and spatial distribution of EGF binding at cell membranes. Our data demonstrate that the mechanical microenvironment tunes Erk signaling dynamics via receptor-ligand interactions, underscoring how multiple microenvironmental signals are jointly processed through a highly conserved pathway that regulates tissue development, homeostasis, and disease progression.


Asunto(s)
Microambiente Celular , Matriz Extracelular/química , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Glándulas Mamarias Humanas/metabolismo , Movimiento Celular , Células Cultivadas , Receptores ErbB/metabolismo , Femenino , Humanos , Glándulas Mamarias Humanas/citología , Fosforilación , Transducción de Señal
4.
Cell Syst ; 6(6): 655-663.e5, 2018 06 27.
Artículo en Inglés | MEDLINE | ID: mdl-29859829

RESUMEN

Protein/RNA clusters arise frequently in spatially regulated biological processes, from the asymmetric distribution of P granules and PAR proteins in developing embryos to localized receptor oligomers in migratory cells. This co-occurrence suggests that protein clusters might possess intrinsic properties that make them a useful substrate for spatial regulation. Here, we demonstrate that protein droplets show a robust form of spatial memory, maintaining the spatial pattern of an inhibitor of droplet formation long after it has been removed. Despite this persistence, droplets can be highly dynamic, continuously exchanging monomers with the diffuse phase. We investigate the principles of biophysical spatial memory in three contexts: a computational model of phase separation; a novel optogenetic system where light can drive rapid, localized dissociation of liquid-like protein droplets; and membrane-localized signal transduction from clusters of receptor tyrosine kinases. Our results suggest that the persistent polarization underlying many cellular and developmental processes could arise through a simple biophysical process, without any additional biochemical feedback loops.


Asunto(s)
Memoria a Largo Plazo/fisiología , Orgánulos/química , Memoria Espacial/fisiología , Simulación por Computador , Retroalimentación Fisiológica , Proteínas de la Membrana/química , Proteínas de la Membrana/metabolismo , Proteínas de Neoplasias/química , Proteínas de Neoplasias/metabolismo , Optogenética/métodos , Proteínas/química , ARN/análisis , Transducción de Señal
5.
Rev. colomb. psiquiatr ; 35(3): 328-340, jul.-sep. 2006. tab
Artículo en Español | LILACS | ID: lil-636319

RESUMEN

Introducción: estudios previos y la percepción del personal que labora en el Servicio Médico de la Universidad del Valle sugieren un comportamiento sexual poco responsable por parte del estamento estudiantil. Objetivo: el presente estudio describe el comportamiento sexual y anticonceptivo en estudiantes de primer, tercer y último año del programa de Medicina. Resultados: al Programa de Medicina ingresan adolescentes tardíos con proporción creciente de mujeres y, en su mayoría, de estrato socioeconómico medio y alto; los estudiantes hombres inician sus relaciones coitales más precozmente que las mujeres (p<0,001), si bien estas últimas están iniciando cada vez más temprano, al punto de no encontrar diferencias entre los sexos en la cohorte del primer año. Se evidencia un comportamiento sexual similar en los dos sexos, con un pequeño porcentaje de ambos sexos que se mantiene virgen (alrededor del 5,3%). Los métodos anticonceptivos más utilizados son el condón y la píldora. La conducta sexual responsable (uso de anticonceptivo en todas las relaciones coitales) prácticamente no se modifica entre los semestres. Existe un incremento significativo en embarazos, abortos inducidos y enfermedades de transmisión sexual (ETS) entre los estudiantes de un nivel de formación y otro. Los argumentos expuestos para no utilizar siempre un contraceptivo son insensatos.


Introduction: Previous research and data arising from the “Universidad del Valle” medical school Health Service suggest that students exhibit irresponsible sexual behavior. Objective: This paper describes sexual behavior and contraceptive methods commonly used among first, third and last year students. Results: Students entering the program are frequently late adolescents, with a growing female proportion, coming from high and middle social and economic classes. Although male students begin coital contacts earlier than females (p<0.001), in recent years this is tending to balance, showing no differences in the freshmen cohorts. Both genders have similar sexual behavior, with a small percentage remaining virgin until internship. Condom and oral contraceptives are favored as contraceptive methods. Medical students exhibit a high degree of risk-taking behavior, therefore unwanted pregnancies, abortions and STDs are frequent and become more prevalent in upper levels. Reasons exposed to avoid the use of contraceptive methods seem invalid and irrelevant.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA